Danone reports robust Q1 2025 sales growth driven by global demand

USA –  Danone, the French multinational food company, announced a strong performance for the first quarter of 2025, with sales reaching US$7.79 billion, marking a 4.3% increase on a like-for-like basis. 

The growth was fueled by rising global demand for its diverse portfolio, including dairy, plant-based products, and specialized nutrition, particularly in regions like China, North Asia, and Oceania.

The company attributed its success to a balanced contribution from volume growth of 1.9% and price increases of 2.4%. 

Danone’s focus on premium health products, such as Activia yogurt, Evian water, and Alpro plant-based offerings, resonated with health-conscious consumers. 

Strong demand for infant milk formula and medical nutrition products in China played a pivotal role, offsetting weaker performance in the U.S. coffee creamer market, where competition and supply chain challenges persisted. 

“We are confident in our ability to capture growth in key categories and deliver value in 2025,” said Antoine de Saint-Affrique, Danone’s CEO.

Danone’s strategic emphasis on innovation and sustainability also contributed to its performance. 

The company recently launched a new Skyr range of Icelandic-style yogurts in the UK, targeting consumers seeking high-protein, nutritious options. 

Meanwhile, its decision to discontinue the Provamel brand in Germany and introduce the Alpro Bio range reflects a shift toward more competitive plant-based offerings. 

Despite these advancements, Danone faces challenges, including the planned closure of a dairy plant in Ochsenfurt, Germany, by late 2026, affecting 230 jobs due to high costs and underutilization.

In Asia, specialized nutrition, particularly infant formula, saw an 11.5% sales surge to US$1.06 billion, underscoring Danone’s adaptability in high-growth markets. 

However, European sales grew modestly at 2.3%, while North and Latin American markets experienced slight declines. 

“Our diversified portfolio and strategic pricing power position us well for sustained growth,” noted Juergen Esser, Danone’s CFO, during a recent earnings call.

Danone reaffirmed its 2025 outlook, projecting like-for-like sales growth of 3% to 5%, with recurring operating income expected to outpace sales. 

The company’s shareholder meeting on April 24 approved a dividend of US$2.44 per share, up 2.4% from last year, signaling confidence in its financial stability. 

As Danone navigates global economic turbulence, its focus on health-driven innovation and emerging markets is expected to drive continued momentum throughout the year.

Subscribe to our email newsletters that provide busy executives like you with the latest news insights and trends from Africa and the World. SUBSCRIBE HERE